Solid Biosciences
SLDB
SLDB
77 hedge funds and large institutions have $83.2M invested in Solid Biosciences in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $132M → $83.2M (-$49M)
60% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 35
Holders
77
Holding in Top 10
–
Calls
$120K
Puts
$19K
Top Buyers
| 1 | +$2.59M | |
| 2 | +$1.13M | |
| 3 | +$793K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$374K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$360K |
Top Sellers
| 1 | -$7.96M | |
| 2 | -$641K | |
| 3 | -$556K | |
| 4 |
BlackRock
New York
|
-$517K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$516K |